vs

Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $21.8M, roughly 1.0× NEKTAR THERAPEUTICS). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -165.4%, a 211.8% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs -25.3%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $-65.0M). Over the past eight quarters, GREENE COUNTY BANCORP INC's revenue compounded faster (18.9% CAGR vs 0.4%).

Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

GCBC vs NKTR — Head-to-Head

Bigger by revenue
GCBC
GCBC
1.0× larger
GCBC
$22.2M
$21.8M
NKTR
Growing faster (revenue YoY)
GCBC
GCBC
+49.1% gap
GCBC
23.8%
-25.3%
NKTR
Higher net margin
GCBC
GCBC
211.8% more per $
GCBC
46.3%
-165.4%
NKTR
More free cash flow
GCBC
GCBC
$71.2M more FCF
GCBC
$6.2M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
GCBC
GCBC
Annualised
GCBC
18.9%
0.4%
NKTR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
GCBC
GCBC
NKTR
NKTR
Revenue
$22.2M
$21.8M
Net Profit
$10.3M
$-36.1M
Gross Margin
Operating Margin
52.0%
-126.9%
Net Margin
46.3%
-165.4%
Revenue YoY
23.8%
-25.3%
Net Profit YoY
37.4%
-596.9%
EPS (diluted)
$0.60
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCBC
GCBC
NKTR
NKTR
Q4 25
$22.2M
$21.8M
Q3 25
$21.5M
$11.8M
Q2 25
$20.5M
$11.2M
Q1 25
$20.1M
$10.5M
Q4 24
$17.9M
$29.2M
Q3 24
$16.9M
$24.1M
Q2 24
$16.6M
$23.5M
Q1 24
$15.7M
$21.6M
Net Profit
GCBC
GCBC
NKTR
NKTR
Q4 25
$10.3M
$-36.1M
Q3 25
$8.9M
$-35.5M
Q2 25
$9.3M
$-41.6M
Q1 25
$8.1M
$-50.9M
Q4 24
$7.5M
$7.3M
Q3 24
$6.3M
$-37.1M
Q2 24
$6.7M
$-52.4M
Q1 24
$5.9M
$-36.8M
Gross Margin
GCBC
GCBC
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
GCBC
GCBC
NKTR
NKTR
Q4 25
52.0%
-126.9%
Q3 25
47.4%
-268.6%
Q2 25
53.5%
-324.2%
Q1 25
44.6%
-425.8%
Q4 24
45.0%
49.2%
Q3 24
39.6%
-142.4%
Q2 24
41.2%
-211.9%
Q1 24
39.4%
-163.7%
Net Margin
GCBC
GCBC
NKTR
NKTR
Q4 25
46.3%
-165.4%
Q3 25
41.2%
-301.3%
Q2 25
45.6%
-372.2%
Q1 25
40.1%
-486.4%
Q4 24
41.7%
24.9%
Q3 24
37.1%
-153.6%
Q2 24
40.6%
-222.9%
Q1 24
37.3%
-170.1%
EPS (diluted)
GCBC
GCBC
NKTR
NKTR
Q4 25
$0.60
$-4.67
Q3 25
$0.52
$-1.87
Q2 25
$0.55
$-2.95
Q1 25
$0.47
$-0.24
Q4 24
$0.44
$-2.07
Q3 24
$0.37
$-2.66
Q2 24
$0.39
$-3.76
Q1 24
$0.34
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCBC
GCBC
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$258.3M
$89.8M
Total Assets
$3.1B
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCBC
GCBC
NKTR
NKTR
Q4 25
$15.1M
Q3 25
$41.0M
Q2 25
$43.0M
Q1 25
$155.5M
$38.9M
Q4 24
$166.4M
$44.3M
Q3 24
$30.1M
Q2 24
$190.4M
$27.9M
Q1 24
$48.6M
Stockholders' Equity
GCBC
GCBC
NKTR
NKTR
Q4 25
$258.3M
$89.8M
Q3 25
$248.2M
$85.1M
Q2 25
$238.8M
$-24.2M
Q1 25
$229.0M
$13.7M
Q4 24
$218.4M
$60.7M
Q3 24
$216.3M
$48.9M
Q2 24
$206.0M
$79.7M
Q1 24
$199.2M
$126.7M
Total Assets
GCBC
GCBC
NKTR
NKTR
Q4 25
$3.1B
$280.4M
Q3 25
$3.1B
$301.3M
Q2 25
$3.0B
$207.5M
Q1 25
$3.0B
$256.2M
Q4 24
$3.0B
$303.9M
Q3 24
$2.9B
$308.0M
Q2 24
$2.8B
$343.3M
Q1 24
$2.9B
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCBC
GCBC
NKTR
NKTR
Operating Cash FlowLast quarter
$6.4M
$-65.0M
Free Cash FlowOCF − Capex
$6.2M
$-65.0M
FCF MarginFCF / Revenue
28.0%
-298.0%
Capex IntensityCapex / Revenue
0.9%
0.1%
Cash ConversionOCF / Net Profit
0.62×
TTM Free Cash FlowTrailing 4 quarters
$47.3M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCBC
GCBC
NKTR
NKTR
Q4 25
$6.4M
$-65.0M
Q3 25
$7.0M
$-48.8M
Q2 25
$28.0M
$-45.7M
Q1 25
$7.3M
$-49.1M
Q4 24
$5.3M
$-46.2M
Q3 24
$2.1M
$-43.9M
Q2 24
$24.9M
$-37.7M
Q1 24
$5.6M
$-47.9M
Free Cash Flow
GCBC
GCBC
NKTR
NKTR
Q4 25
$6.2M
$-65.0M
Q3 25
$6.5M
$-48.9M
Q2 25
$27.3M
$-45.8M
Q1 25
$7.3M
$-49.1M
Q4 24
$5.1M
$-46.6M
Q3 24
$2.0M
$-44.6M
Q2 24
$23.4M
$-37.9M
Q1 24
$4.9M
$-48.0M
FCF Margin
GCBC
GCBC
NKTR
NKTR
Q4 25
28.0%
-298.0%
Q3 25
30.4%
-414.5%
Q2 25
133.3%
-409.6%
Q1 25
36.1%
-469.0%
Q4 24
28.6%
-159.9%
Q3 24
11.8%
-184.9%
Q2 24
141.2%
-161.3%
Q1 24
31.3%
-222.0%
Capex Intensity
GCBC
GCBC
NKTR
NKTR
Q4 25
0.9%
0.1%
Q3 25
1.9%
1.0%
Q2 25
3.4%
0.3%
Q1 25
0.3%
0.0%
Q4 24
1.0%
1.6%
Q3 24
0.9%
2.8%
Q2 24
9.1%
0.8%
Q1 24
4.2%
0.7%
Cash Conversion
GCBC
GCBC
NKTR
NKTR
Q4 25
0.62×
Q3 25
0.78×
Q2 25
3.00×
Q1 25
0.91×
Q4 24
0.71×
-6.36×
Q3 24
0.34×
Q2 24
3.70×
Q1 24
0.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons